Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2025.
All research outputs
#1,650,130
of 34,518,147 outputs
Outputs from British Medical Journal
#14,085
of 75,822 outputs
Outputs of similar age
#3,081
of 116,864 outputs
Outputs of similar age from British Medical Journal
#35
of 242 outputs
Altmetric has tracked 34,518,147 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 75,822 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.5. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 116,864 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 242 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.
